Russia launches another round of airstrikes in Syria. In Afghanistan, fighting with the Taliban continues in Kunduz. And a Palestinian flag flies at the U.N. for the first time. A panel of journalists joins guest host Melissa Block for analysis of the week's top international news stories.
An estimated 2.5 million people work as in-home health and personal aides for the elderly and disabled in this country. Tasks include helping with meals and bathing, light cleaning and companionship. These services can allow an elderly person to postpone or avoid costlier nursing home care. As baby boomers age, demand for this kind of care is projected to rise significantly. But in many states, in-home health care providers earn less than minimum wage and are not entitled to overtime. What the shortage of caregivers means for patients, their families and the home health care industry.
- Susan Dentzer senior policy adviser at the Robert Wood Johnson Foundation and on-air analyst on health issues for the PBS NewsHour.
- Bruce Vladeck former director of Medicare and Medicaid during the Clinton administration.
- Val Halamandaris president of the National Association for Home Care and Hospice.
- Carol Regan government affairs director at PHI, Paraprofessional Healthcare Institute.
Most Recent Shows
Nine people and a gunman are dead after a shooting at an Oregon community college. Bernie Sanders narrows the fundraising gap with Hillary Clinton in the last quarter. And Congress avoids a government shutdown – for now. A panel of journalists joins guest host Melissa Block of NPR News for analysis of the week's top national news stories.
Russian President Putin is widely popular in Russia, despite his ruthless reputation abroad. A former Moscow bureau chief for The New York Times explains how Putin rose from obscurity to become one of the world’s most powerful and enigmatic leaders.
The owner of a drug company has come under fire for dramatically raising the price of medicine that fights deadly infections. And the prices of some heart medications have also spiked. We look at the renewed controversy over high drug prices in the U.S.